Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity on Wednesday, becoming a late contender in the race to offer a ...

president of Merck Research Laboratories, said in a statement. Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.

Merck (MRK) and Esai (ESALF) (ESAIY) announce a mixed outcome in their Phase 3 LEAP-015 trial for Keytruda/ Lenvima regimen ...

Merck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex ...

Keytruda only uses the PD-1 pathway. Eliav Barr, chief medical officer at Merck Research Laboratories, said blocking both ...

Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while ...

“We continue to leverage science-driven business development to augment and complement our robust pipeline,” said Dean Li, president of Merck Research Laboratories. “Through this ...

Merck Research Laboratories. “We look forward to working alongside the FDA on the review of clesrovimab, which, if approved, would be the first and only single dose immunization for infants ...

Merck Research Laboratories, said: “As part of Merck’s 30-year commitment to the care of people with HIV, we are pleased to now bring forward these two new antiretroviral treatment options ...

Merck Research Laboratories. “We continue to believe LAGEVRIO may be an important option for people with risk factors like older age, multiple comorbidities, and immunocompromising conditions ...

Atropos Health, a pioneer in translating real-world clinical data into real-world evidence (RWE) for decision-making, today ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...